Evaluation of YAP as a therapeutic target in HCC and CCA

被引:0
|
作者
Bai, Haibo [1 ,2 ]
Quy Nguyen [4 ]
Zhu, Qingfeng [3 ]
Alpini, Gianfranco [1 ,2 ,4 ]
Anders, Robert [3 ]
机构
[1] Baylor Scott & White Healthcare, Digest Dis Res Ctr, Temple, TX USA
[2] Texas A&M Univ, Coll Med, Internal Med, Temple, TX 76508 USA
[3] Johns Hopkins Univ, Sch Med, Pathol, Baltimore, MD USA
[4] Cent Texas Vet Hlth Care Syst, Res Serv, Temple, TX USA
来源
FASEB JOURNAL | 2015年 / 29卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
45.4
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Met as a therapeutic target in HCC: Facts and hopes
    Giordano, Silvia
    Columbano, Amedeo
    JOURNAL OF HEPATOLOGY, 2014, 60 (02) : 442 - 452
  • [2] Yap1 AS A THERAPEUTIC TARGET IN FIBROLAMELLAR CARCINOMA
    Oh, Seh-Hoon
    Jewell, Mark
    Premont, Richard T.
    Gibson, Jason
    Glover, Wayne
    Gregory, Simon G.
    Hsu, David
    Guy, Cynthia D.
    Diehl, Anna Mae
    HEPATOLOGY, 2019, 70 : 888A - 889A
  • [3] YAP as a potential therapeutic target for myofibroblast formation in asthma
    Guo, Yanrong
    Zhou, Yuran
    Wang, Rui
    Lin, Yujing
    Lan, Huimin
    Li, Yang
    Wang, De-Yun
    Dong, Jinrui
    Li, Kefeng
    Yan, Yan
    Qiao, Yongkang
    RESPIRATORY RESEARCH, 2025, 26 (01)
  • [4] Yap1 As a Therapeutic Target in Fibrolamellar Carcinoma
    Jewell, Mark
    Premont, Richard T.
    Gibson, Jason
    Glover, Wayne
    Dinh, Timothy A.
    Wauthier, Eliane L.
    Reid, Lola M.
    Gregory, Simon G.
    Sethupathy, Praveen
    Hsu, David S.
    Diehl, Anna Mae
    HEPATOLOGY, 2018, 68 : 1243A - 1243A
  • [5] Circular RNA as a Novel Biomarker and Therapeutic Target for HCC
    Meng, Hongwu
    Niu, Ruowen
    Huang, Cheng
    Li, Jun
    CELLS, 2022, 11 (12)
  • [6] A new therapeutic target for HCV-related HCC
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (04) : 422 - 422
  • [7] YAP/TAZ EXPRESSION IN HEPATOCELLULAR CARCINOMA(HCC) AND EFFECTS OF YAP/TAZ INHIBITION ON HCC
    Han, Sojung
    Ro, Simon Wonsang
    Seo, Haeng Ran
    Kim, Kyung Sik
    Park, Jun Yong
    Kim, Do Young
    HEPATOLOGY, 2021, 74 : 717A - 718A
  • [8] Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
    Wei, Yulong
    Song, Qingzhu
    Zhang, Fenglan
    Yuan, Tian
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 2021
  • [9] Kynurenine metabolism as a biomarker and therapeutic target in hepatocellular carcinoma (HCC)
    Castro-Portuguez, Raul
    Freitas, Samuel
    Sutphin, George L.
    CANCER RESEARCH, 2020, 80 (16)
  • [10] RalA signaling pathway as a therapeutic target in hepatocellular carcinoma (HCC)
    Ezzeldin, Mohamad
    Borrego-Diaz, Emma
    Taha, Mohammad
    Esfandyari, Tuba
    Wise, Amanda L.
    Peng, Warner
    Rouyanian, Alex
    Kermani, Atabak Asvadi
    Soleimani, Mina
    Patrad, Elham
    Lialyte, Kristina
    Wang, Kun
    Williamson, Stephen
    Abdulkarim, Bashar
    Olyaee, Mojtaba
    Farassati, Faris
    MOLECULAR ONCOLOGY, 2014, 8 (05) : 1043 - 1053